I have screened several tumor models (Panc02, 4T1, E0771 and EMT6) for CAF markers (such as FSP-1 and PDGF receptor) through flow cytometric analysis - the population of live CAFs in each model are about 1-3% CAFs.

Is there any way I could increase the content of CAFs in tumors? Could I simply co-inoculate mice with murine fibroblasts/cancer cell suspensions to reshape the stromal architecture of syngeneic tumor models?

More James D Barnett's questions See All
Similar questions and discussions